Synthetic DDAVP for nocturnal enuresis and the risk of symptomatic hyponatremia: which treatment now? Which form?
UMass Chan Affiliations
Department of PediatricsDocument Type
Journal ArticlePublication Date
2007-06-01
Metadata
Show full item recordAbstract
Recently, several cases of seizure secondary to hyponatremia have been reported in children treated with intranasal DDAVP1), 2). This has rarely been reported with the oral form. Should the intranasal form be banned for the treatment of nocturnal enuresis (NE)? Or should any form of DDAVP be banned? What are the precautions to take to avoid such an event? We hereunder summarize the literature on the subject, and present the recommendations of the Swiss Group for Pediatric Nephrology and the current position of Swiss medic.Source
Cachat F (for the Swiss Group of Pediatric Nephrology): Synthetic DDAVP for Nocturnal Enuresis and the Risk of Symptomatic Hyponatremia: Which Treatment Now? Which Form? Paediatrica 18(6):54-56, 2007.
Permanent Link to this Item
http://hdl.handle.net/20.500.14038/43521Notes
Citation: Cachat F (for the Swiss Group of Pediatric Nephrology): Synthetic DDAVP for Nocturnal Enuresis and the Risk of Symptomatic Hyponatremia: Which Treatment Now? Which Form? Paediatrica 18(6):54-56, 2007.
This publication is in the public domain, http://www.creativecommons.org/licenses/publicdomain.
Rights
This publication is in the public domain, http://www.creativecommons.org/licenses/publicdomain.